UK Daily Mail
April 15, 2011
A ‘universal’ vaccine that could revolutionise the treatment of cancer could be available in just two years.
The TeloVac jab is part of a new generation of drugs that use the body’s own defences to fight the disease, stopping tumours in their tracks.
TeloVac has already been given to hundreds of Britons with pancreatic cancer, one of the deadliest forms of the disease.
But it is hoped it will be effective against many other tumours, including those of the skin, lung and liver. Breast and prostate cancers may also be within its grasp.
Together, the six forms of the disease claim more 70,000 lives a year in the UK.